Are There Any Emerging Therapies in Cancer Immunotherapy?
Several emerging therapies are showing promise in the field of cancer immunotherapy. _Oncolytic viruses_ are engineered viruses that selectively infect and kill cancer cells while stimulating an immune response. _Bispecific T cell engagers (BiTEs)_ are antibodies that can simultaneously bind to T cells and cancer cells, facilitating targeted killing. Additionally, _personalized neoantigen vaccines_ are being developed to tailor immune responses based on individual tumor profiles.
